Related Experiment Videos
Preliminary Outcomes of a Brief Values-Guided Self-Management Intervention to Improve Glucose Levels Among Emerging
Sara E Styles1, Jillian J Haszard2, Zuzana Oravcova-Wheeler3
1Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
Introduction:
A minority of young adults with type 1 diabetes achieve > 70% time in range (TIR; 70-180 mg/dL [3.9-10 mmol/L]), as recommended. Self-management goals based on self-chosen values (whatever is most important to an individual) may motivate engagement in self-management tasks that could improve TIR. This study explored the acceptability, feasibility, and potential outcomes of values-guided self-management.
Methods:
A single-arm quasi-experimental pilot study was conducted with 14 participants aged 18-25 years and HbA1c ≥ 58 mmol/mol (7.5%). The intervention consisted of a single 1:1 session (< 60 min) grounded in Acceptance and Commitment Therapy and a 2-week follow-up. The session consisted of a semi-structured discussion of self-management behaviour, behavioural alignment with personally chosen values, barriers to behaviour change, and action planning. TIR was determined by glucose levels measured with a blinded interstitial continuous glucose monitoring sensor. Participants self-reported adherence to self-management tasks, psychological flexibility, valued living and acceptance of living with diabetes.
Results:
Fourteen participants received the intervention. The intervention was acceptable and feasible to implement. The mean change (95% CI) between pre- and post-intervention TIR was an increase of 2.2 (-1.2, 5.7) percentage points, mostly through a decrease in time above range. The standardized mean change (95% CI) in progress towards valued living was 0.72 (0.27, 1.16) with small improvements in diabetes-specific acceptance and carrying out valued actions.
Conclusions:
A brief values-guided self-management intervention shows promise to improve time in range among emerging adults with type 1 diabetes and above recommended HbA1c. Further investigation of values-guided self-management is warranted.
Trial Registration:
Australian New Zealand Clinical Trials Registry (ACTRN12620000200987; https://www.anzctr.org.au/ACTRN12620000200987.aspx).
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes III: Clinical Manifestations